The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Vitiligo: A focus on pathogenesis and its therapeutic implications
Abstract
Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population worldwide. The characteristic white patches result from the selective loss of melanocytes. Sustained recent efforts have resulted in a detailed understanding of the genetic architecture of vitiligo. About 80% of vitiligo risk is attributable to genetic factors; and the rest (20%) is attributable to the environment. Over the past decade, substantial progress has been made in our understanding of the pathogenesis of vitiligo which is now clearly classified as an autoimmune disease. Melanocytes from patients with vitiligo are more susceptible to oxidative stress which begets the release of exosomes and inflammatory cytokines that will lead to activation of the innate immune response and subsequently to adaptive immune response through activation of autoreactive cytotoxic CD8+ T cells. These produce interferon‐γ (IFN‐γ) which promotes disease progression through IFN‐γ‐induced chemokine secretion from surrounding keratinocytes to further recruit T cells to the skin through a positive feedback loop. CD8 tissue‐resident memory T cells are in turn responsible for long‐term maintenance and potential relapse of vitiligo in human patients through cytokine‐mediated recruitment of T cells from the circulation. This review summarizes the current knowledge on vitiligo and attempt to give an overview of the future in vitiligo treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Oxidative Stress in the Pathogenesis of Skin Disease
Bickers, D. R., & Athar, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700340 · Cited by 1,092
Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60763-7 · Cited by 943
Self-citationEpidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families
Alkhateeb, A., Fain, P. R., Thody, A., Bennett, D. C., & Spritz, R. A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00032.x · Cited by 728
Vitiligo: A comprehensive overview
Alikhan, A., Felsten, L. M., Daly, M., & Petronic-Rosic, V. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.061 · Cited by 708
Ezzedine, K., Lim, H. W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C. C. E., Goh, B. K., Anbar, T., Silva de Castro, C., Lee, A. Y., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00997.x · Cited by 702
Self-citationCD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin
Cheuk, S., Schlums, H., Gallais Sérézal, I., Martini, E., Chiang, S. C., Marquardt, N., Gibbs, A., Detlofsson, E., Introini, A., Forkel, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.009 · Cited by 678
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Schwartz, D. M., Bonelli, M., Gadina, M., & O'Shea, J. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.167 · Cited by 648
NALP1 in Vitiligo-Associated Multiple Autoimmune Disease
Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., Fain, P. R., & Spritz, R. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061592 · Cited by 630
Vitiligo: Mechanisms of Pathogenesis and Treatment
Frisoli, M. L., Essien, K., & Harris, J. E. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100919-023531 · Cited by 618
A review of the worldwide prevalence of vitiligo in children/adolescents and adults
Krüger, C., & Schallreuter, K. U. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05377.x · Cited by 571
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
van den Boorn, J. G., Konijnenberg, D., Dellemijn, T. A. M., Wietze van der Veen, J. P., Bos, J. D., Melief, C. J. M., Vyth-Dreese, F. A., & Luiten, R. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.32 · Cited by 543
Rashighi, M., Agarwal, P., Richmond, J. M., Harris, T. H., Dresser, K., Su, M.-W., Zhou, Y., Deng, A., Hunter, C. A., Luster, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007811 · Cited by 518
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force
Taïeb, A., Picardo, M., & members, O. B. O. T. O. V. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00355.x · Cited by 517
New discoveries in the pathogenesis and classification of vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.048 · Cited by 476
Self-citationHigh Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1203 · Cited by 460
Taieb, A., Alomar, A., Böhm, M., Dell’Anna, M. L., De Pase, A., Eleftheriadou, V., Ezzedine, K., Gauthier, Y., Gawkrodger, D. J., Jouary, T., et al. (2013) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11197.x · Cited by 450
Self-citationVega, V. L., Rodríguez-Silva, M., Frey, T., Gehrmann, M., Diaz, J. C., Steinem, C., Multhoff, G., Arispe, N., & De Maio, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4299 · Cited by 449
Evidence for an Autoimmune Pathogenesis of Vitiligo
Ongenae, K., Van Geel, N., & Naeyaert, J. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00023.x · Cited by 437
Melanocytes as Instigators and Victims of Oxidative Stress
Denat, L., Kadekaro, A. L., Marrot, L., Leachman, S. A., & Abdel-Malek, Z. A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.65 · Cited by 416
Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Gowan, K., Riccardi, S. L., Holland, P. J., Mailloux, C. M., Sufit, A. J. D., Hutton, S. M., Amadi-Myers, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908547 · Cited by 415
Self-citationHarris, J. E., Harris, T. H., Weninger, W., John Wherry, E., Hunter, C. A., & Turka, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.463 · Cited by 389
Jin, Y., Andersen, G., Yorgov, D., Ferrara, T. M., Ben, S., Brownson, K. M., Holland, P. J., Birlea, S. A., Siebert, J., Hartmann, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3680 · Cited by 355
Self-citationGenome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Ferrara, T. M., Ben, S., Riccardi, S. L., Cole, J. B., Gowan, K., Holland, P. J., Bennett, D. C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2272 · Cited by 353
Self-citationLow Catalase Levels in the Epidermis of Patients with Vitiligo
Schallreuter, K. U., Wood, J. M., & Berger, J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12492612 · Cited by 347
Guideline for the diagnosis and management of vitiligo
Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J., Anstey, A. V., Ingham, J., & Young, K. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08881.x · Cited by 332
Picardo, M., Dell'Anna, M. L., Ezzedine, K., Hamzavi, I., Harris, J. E., Parsad, D., & Taieb, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.11 · Cited by 326
Self-citationMaresca, V., Roccella, M., Roccella, F., Camera, E., Del Porto, G., Passi, S., Grammatico, P., & Picardo, M. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12335801 · Cited by 302
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
Richmond, J. M., Strassner, J. P., Zapata, L., Garg, M., Riding, R. L., Refat, M. A., Fan, X., Azzolino, V., Tovar-Garza, A., Tsurushita, N., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7710 · Cited by 301
The Prevalence of Vitiligo: A Meta-Analysis
Zhang, Y., Cai, Y., Shi, M., Jiang, S., Cui, S., Wu, Y., Gao, X.-H., & Chen, H.-D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163806 · Cited by 292
Poole, I. C. L., van den Wijngaard, R. M., Westerhof, W., & Das, P. K. (1996) · Europe PMC (PubMed Central) · Cited by 282
Local Immune Response in Skin of Generalized Vitiligo Patients
van den Wijngaard, R., Wankowicz-Kalinska, A., Le Poole, C., Tigges, B., Westerhof, W., & Das, P. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780138 · Cited by 272
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Rosmarin, D., Pandya, A. G., Lebwohl, M., Grimes, P., Hamzavi, I., Gottlieb, A. B., Butler, K., Kuo, F., Sun, K., Ji, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30609-7 · Cited by 271
Review of the etiopathomechanism of vitiligo: A convergence theory
Le Poole, I. C., Das, P. K., van den Wijngaard, R. M. J. G. J., Bos, J. D., & Westerhof, W. (1993) · Experimental Dermatology · doi:10.1111/j.1600-0625.1993.tb00023.x · Cited by 268
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
Boniface, K., Jacquemin, C., Darrigade, A.-S., Dessarthe, B., Martins, C., Boukhedouni, N., Vernisse, C., Grasseau, A., Thiolat, D., Rambert, J., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.08.038 · Cited by 263
Self-citationWańkowicz-Kalińska, A., van den Wijngaard, R. M. J. G. J., Tigges, B. J., Westerhof, W., Ogg, G. S., Cerundolo, V., Storkus, W. J., & Das, P. K. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069521.42488.1b · Cited by 262
Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy
Craiglow, B. G., & King, B. A. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.1520 · Cited by 259
Jimbow, K., Chen, H., Park, J.-S., & Thomas, P. D. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.03952.x · Cited by 253
Targeting the Janus Kinase Family in Autoimmune Skin Diseases
Howell, M. D., Kuo, F. I., & Smith, P. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02342 · Cited by 251
Vitiligo: Compendium of clinico-epidemiological features
Sehgal, V., & Srivastava, G. (2007) · Indian Journal of Dermatology, Venereology and Leprology · doi:10.4103/0378-6323.32708 · Cited by 250
Segmental vitiligo: Clinical findings in 208 patients
Hann, S. K., & Lee, H. J. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90718-5 · Cited by 246
Phototherapy for Vitiligo: A Systematic Review and Meta-analysis
Bae, J. M., Jung, H. M., Hong, B. Y., Lee, J. H., Choi, W. J., Lee, J. H., & Kim, G. M. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2017.0002 · Cited by 242
Richmond, J. M., Bangari, D. S., Essien, K. I., Currimbhoy, S. D., Groom, J. R., Pandya, A. G., Youd, M. E., Luster, A. D., & Harris, J. E. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.016 · Cited by 235
Innate immune mechanisms in vitiligo: danger from within
Richmond, J. M., Frisoli, M. L., & Harris, J. E. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.010 · Cited by 225
Palermo, B., Campanelli, R., Garbelli, S., Mantovani, S., Lantelme, E., Brazzelli, V., Ardigó, M., Borroni, G., Martinetti, M., Badulli, C., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01408.x · Cited by 223
Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
Xie, H., Zhou, F., Liu, L., Zhu, G., Li, Q., Li, C., & Gao, T. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.09.003 · Cited by 214
Spritz, R. A., & Andersen, G. H. L. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.013 · Cited by 207
Norris, D. A., Kissinger, R. M., Naughton, G. M., & Bystryn, J. C. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12461505 · Cited by 205
Toosi, S., Orlow, S. J., & Manga, P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.181 · Cited by 203
A Systematic Review of Autologous Transplantation Methods in Vitiligo
Njoo, M. D., Westerhof, W., Bos, J. D., & Bossuyt, P. M. M. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.12.1543 · Cited by 202
Cavalié, M., Ezzedine, K., Fontas, E., Montaudié, H., Castela, E., Bahadoran, P., Taïeb, A., Lacour, J.-P., & Passeron, T. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.527 · Cited by 199
Self-citationYang, L., Wei, Y., Sun, Y., Shi, W., Yang, J., Zhu, L., & Li, M. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2080 · Cited by 199
Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo
Gauthier, Y., Cario-Andre, M., Lepreux, S., Pain, C., & Taieb, A. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05024.x · Cited by 199
Harris, J. E., Rashighi, M., Nguyen, N., Jabbari, A., Ulerio, G., Clynes, R., Christiano, A. M., & Mackay-Wiggan, J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.09.073 · Cited by 199
Li, S., Zhu, G., Yang, Y., Jian, Z., Guo, S., Dai, W., Shi, Q., Ge, R., Ma, J., Liu, L., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.013 · Cited by 199
Current and emerging treatments for vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.11.010 · Cited by 196
Self-citationRegazzetti, C., Joly, F., Marty, C., Rivier, M., Mehul, B., Reiniche, P., Mounier, C., Rival, Y., Piwnica, D., Cavalié, M., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.335 · Cited by 194
Prevalence of Vitiligo: Epidemiological Survey on the Isle of Bornholm, Denmark
Howitz, J. (1977) · Archives of Dermatology · doi:10.1001/archderm.1977.01640010049006 · Cited by 194
Cellular and developmental aspects of androgenetic alopecia
Jahoda, C. A. B. (1998) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00666.x · Cited by 192
Wang, X. X., Wang, Q. Q., Wu, J. Q., Jiang, M., Chen, L., Zhang, C. F., & Xiang, L. H. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14416 · Cited by 191
Pattern of Familial Aggregation of Vitiligo
Majumder, P. P. (1993) · Archives of Dermatology · doi:10.1001/archderm.1993.01680290066010 · Cited by 189
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
Rothstein, B., Joshipura, D., Saraiya, A., Abdat, R., Ashkar, H., Turkowski, Y., Sheth, V., Huang, V., Au, S. C., Kachuk, C., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.02.049 · Cited by 189
Lim, H. W., Grimes, P. E., Agbai, O., Hamzavi, I., Henderson, M., Haddican, M., Linkner, R. V., & Lebwohl, M. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.1875 · Cited by 188
Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)
Lilly, E., Lu, P. D., Borovicka, J. H., Victorson, D., Kwasny, M. J., West, D. P., & Kundu, R. V. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.01.038 · Cited by 187
Vitiligo and Other Diseases: Coexistence or True Association?
Schallreuter, K. U., Lemke, R., Brandt, O., Schwartz, R., Westhofen, M., Montz, R., & Berger, J. (1994) · Dermatology · doi:10.1159/000247164 · Cited by 186
Tulic, M. K., Cavazza, E., Cheli, Y., Jacquel, A., Luci, C., Cardot-Leccia, N., Hadhiri-Bzioueche, H., Abbe, P., Gesson, M., Sormani, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09963-8 · Cited by 178
Reduced skin homing by functional Treg in vitiligo: Absence of Treg in vitiligo skin
Klarquist, J., Denman, C. J., Hernandez, C., Wainwright, D. J., Strickland, F. M., Overbeck, A., Mehrotra, S., Nishimura, M. I., & Le Poole, I. C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00688.x · Cited by 176
Lili, Y., Yi, W., Ji, Y., Yue, S., Weimin, S., & Ming, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037513 · Cited by 176
Kroll, T. M., Bommiasamy, H., Boissy, R. E., Hernandez, C., Nickoloff, B. J., Mestril, R., & Caroline Le Poole, I. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23653.x · Cited by 175
Njoo, M. D., Vodegel, R. M., & Westerhof, W. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.103813 · Cited by 174
A review and a new hypothesis for non‐immunological pathogenetic mechanisms in vitiligo
Dell'Anna, M. L., & Picardo, M. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00333.x · Cited by 173
Immunopathogenesis of vitiligo
Sandoval-Cruz, M., García-Carrasco, M., Sánchez-Porras, R., Mendoza-Pinto, C., Jiménez-Hernández, M., Munguía-Realpozo, P., & Ruiz-Argüelles, A. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.02.004 · Cited by 172
Autoimmunity as an aetiological factor in vitiligo
Rezaei, N., Gavalas, N., Weetman, A., & Kemp, E. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02228.x · Cited by 166
Wagner, R. Y., Luciani, F., Cario-André, M., Rubod, A., Petit, V., Benzekri, L., Ezzedine, K., Lepreux, S., Steingrimsson, E., Taieb, A., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.25 · Cited by 166
Self-citationAn immunohistological study of cutaneous lymphocytes in vitiligo
Badri, A. M. T. A., Todd, P. M., Garioch, J. J., Gudgeon, J. E., Stewart, D. G., & Goudie, R. B. (1993) · The Journal of Pathology · doi:10.1002/path.1711700209 · Cited by 165
Richmond, J. M., Strassner, J. P., Rashighi, M., Agarwal, P., Garg, M., Essien, K. I., Pell, L., & Harris, J. E. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.10.032 · Cited by 165
PASRICHA, J. S., & KHAITAN, B. K. (1993) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1993.tb02754.x · Cited by 164
Genetic epidemiology of vitiligo: multilocus recessivity cross-validated.
Nath, S. K., Majumder, P. P., & Nordlund, J. J. (1994) · PubMed · Cited by 163
van den Boorn, J. G., Picavet, D. I., van Swieten, P. F., van Veen, H. A., Konijnenberg, D., van Veelen, P. A., van Capel, T., de Jong, E. C., Reits, E. A., Drijfhout, J. W., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.16 · Cited by 160
Type I interferon signature in the initiation of the immune response in vitiligo
Bertolotti, A., Boniface, K., Vergier, B., Mossalayi, D., Taieb, A., Ezzedine, K., & Seneschal, J. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12219 · Cited by 160
Self-citationHasse, S., Gibbons, N. C. J., Rokos, H., Marles, L. K., & Schallreuter, K. U. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22230.x · Cited by 157
Nicolaidou, E., Antoniou, C., Stratigos, A., Stefanaki, C., & Katsambas, A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.09.004 · Cited by 156
Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune Pathogenesis
Spritz, R. A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.321 · Cited by 154
Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
Prajapati, K., Pérez, C., Plaza-Rojas, L., Burke, B., & Guevara-Patino, J. A. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.161 · Cited by 154
Vitiligo is not a cosmetic disease
Ezzedine, K., Sheth, V. M., Rodrigues, M. A., Eleftheriadou, V., Harris, J. E., Hamzavi, I. H., & Pandya, A. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.07.039 · Cited by 149
Self-citationQuality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients
Elbuluk, N., & Ezzedine, K. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.002 · Cited by 149
Self-citationSpritz, R. A., & Santorico, S. A. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.06.004 · Cited by 148
Koebner’s phenomenon in vitiligo: European position paper
van Geel, N., Speeckaert, R., Taïeb, A., Picardo, M., Böhm, M., Gawkrodger, D. J., Schallreuter, K. U., Bennett, D. C., van der Veen, W., Whitton, M. E., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00838.x · Cited by 147
Self-citationCombined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo: A Pilot Study
Kawalek, A. Z., SPENCER, J. M., & Phelps, R. G. (2004) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2004.30058.x · Cited by 147
Genetic Variations in NALP1 Are Associated with Generalized Vitiligo in a Romanian Population
Jin, Y., Birlea, S. A., Fain, P. R., & Spritz, R. A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700953 · Cited by 146
Clinical features and course of type A and type B vitiligo
Koga, M., & Tango, T. (1988) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1988.tb01778.x · Cited by 146
Birlea, S. A., Jin, Y., Bennett, D. C., Herbstman, D. M., Wallace, M. R., McCormack, W. T., Kemp, E. H., Gawkrodger, D. J., Weetman, A. P., Picardo, M., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.337 · Cited by 143
Self-citationMitochondrial Impairment in Peripheral Blood Mononuclear Cells During the Active Phase of Vitiligo
Dell’Anna, M. L., Maresca, V., Briganti, S., Camera, E., Picardo, M., & Falchi, M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01459.x · Cited by 143
Morrone, A., Picardo, M., Luca, C. D., TERMINALI, O., Passi, S., & IPPOLITO, F. (1992) · Pigment Cell Research · doi:10.1111/j.1600-0749.1992.tb00003.x · Cited by 142
Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo
Mosenson, J. A., Zloza, A., Nieland, J. D., Garrett-Mayer, E. S., Eby, J. M., Huelsmann, E. J., Kumar, P., Denman, C. J., Lacek, A. T., Kohlhapp, F. J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005127 · Cited by 142
Yu, R., Broady, R. C., Huang, Y., Wang, Y., Yu, J., Gao, M., Levings, M. K., Wei, S., Zhang, S., Xu, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051040 · Cited by 140
Mohammad, T. F., Al-Jamal, M., Hamzavi, I. H., Harris, J. E., Leone, G., Cabrera, R., Lim, H. W., Pandya, A. G., & Esmat, S. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.041 · Cited by 138
Studies on vitiligo I. Epidemiological profile in Calcutta, India
Das, S., Majumder, P. P., Chakrabotry, R., Majumdar, T. K., Haldar, B., & Rao, D. C. (1985) · Genetic Epidemiology · doi:10.1002/gepi.1370020107 · Cited by 136
Detection of Antibodies to Melanocytes in Vitiligo by Specific Immunoprecipitation
Naughton, G. K., Eisinger, M., & Bystryn, J. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12522891 · Cited by 136
Osinubi, O., Grainge, M. J., Hong, L., Ahmed, A., Batchelor, J., Grindlay, D. J. C., Thompson, A. R., & Ratib, S. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16049 · Cited by 136
Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics
Dwivedi, M., Kemp, E. H., Laddha, N. C., Mansuri, M. S., Weetman, A. P., & Begum, R. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.002 · Cited by 135
Chen, Y.-F., Yang, P., Hu, D., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.12.013 · Cited by 135
Tyrosinase as an autoantigen in patients with vitiligo
Baharav, E., Merimski, O., Shoenfeld, Y., et al. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-727.x · Cited by 132
Rao, G. R., Rao, A. D., Moorthy, B., Rao, T., Sravani, P., Babu, N. K., & Gopal, K. V. T. (2009) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.48427 · Cited by 131
Sasaki, M., Kondo, M., Sato, K., Umeda, M., Kawabata, K., Takahashi, Y., Suzuki, T., Matsunaga, K., & Inoue, S. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12269 · Cited by 130
Thulasingam, S., Massilamany, C., Gangaplara, A., Dai, H., Yarbaeva, S., Subramaniam, S., Riethoven, J.-J. M., Eudy, J. D., Lou, M. F., & Reddy, J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0752-2 · Cited by 128
Oiso, N., Fukai, K., Kawada, A., & Suzuki, T. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01583.x · Cited by 127
Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics
Nicolaidou, E., Antoniou, C., Miniati, A., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.07.010 · Cited by 126
Shen, C., Gao, J., Sheng, Y., Dou, J., Zhou, F., Zheng, X., Ko, R., Tang, X., Zhu, C., Yin, X., et al. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00003 · Cited by 122
Kostopoulou, P., Jouary, T., Quintard, B., Ezzedine, K., Marques, S., Boutchneï, S., & Taïeb, A. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09077.x · Cited by 121
Self-citationKakourou, T., Kanaka‐Gantenbein, C., Papadopoulou, A., Kaloumenou, E., & Chrousos, G. P. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.032 · Cited by 119
An epidemiologic case-control study in a population with vitiligo
Barona, M. I., Arrunátegui, A., Rafael Falabella, F., & Alzate, A. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91282-7 · Cited by 119
Dysregulated autophagy increased melanocyte sensitivity to H2O2-induced oxidative stress in vitiligo
He, Y., Li, S., Zhang, W., Dai, W., Cui, T., Wang, G., Gao, T., & Li, C. (2017) · Scientific Reports · doi:10.1038/srep42394 · Cited by 119
Clinical profiles of vitiligo in China: an analysis of 3742 patients
Liu, J.-B., Li, M., Yang, S., et al. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01813.x · Cited by 118
A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo
Chatterjee, S., Eby, J. M., Al-Khami, A. A., Soloshchenko, M., Kang, H.-K., Kaur, N., Naga, O. S., Murali, A. K., Nishimura, M. I., Poole, I. C. L., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.540 · Cited by 117
Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo
Ahmed, M. B., Zarâa, I., Rekik, R., Elbeldi-Ferchiou, A., Kourda, N., Hmida, N. B., Abdeladhim, M., Karoui, O., Osman, A. B., Mokni, M., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00920.x · Cited by 115
Surgical interventions for vitiligo: an evidence-based review
Mulekar, S. V., & Isedeh, P. N. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12532 · Cited by 113
Direct Evidence to Support the Role of Antigen-Specific CD8+ T Cells in Melanoma-Associated Vitiligo
Gal, F. L., Lefebvre, P., Deschemin, J., Andrieu, M., Guillet, J., Avril, M., Bosq, J., & Dore, M.-X. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01605.x · Cited by 113
Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo
Agarwal, P., Rashighi, M., Essien, K. I., Richmond, J. M., Randall, L. M., Pazoki–Toroudi, H., Hunter, C. A., & Harris, J. E. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.529 · Cited by 113
Speeckaert, R., Dugardin, J., Lambert, J., Lapeere, H., Verhaeghe, E., Speeckaert, M. M., & van Geel, N. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14792 · Cited by 113
Vitiligo: A Possible Model of Degenerative Diseases
Bellei, B., Pitisci, A., Ottaviani, M., Ludovici, M., Cota, C., Luzi, F., Dell’Anna, M. L., & Picardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059782 · Cited by 112
Developing core outcome set for vitiligo clinical trials: international e‐Delphi consensus
Eleftheriadou, V., Thomas, K. S., van Geel, N., Hamzavi, I. H., Lim, H. W., Suzuki, T., Katayama, I., Anbar, T. S., Abdallah, M., Benzekri, L., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12354 · Cited by 111
Self-citationMembrane Lipid Alterations as a Possible Basis for Melanocyte Degeneration in Vitiligo
Dell’Anna, M. L., Ottaviani, M., Albanesi, V., Vidolin, A. P., Leone, G., Ferraro, C., Cossarizza, A., Rossi, L. C., & Picardo, M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700700 · Cited by 111
Prevalence of Vitiligo and Associated Comorbidities in Korea
Lee, H., Lee, M., Lee, D., Kang, H. Y., Kim, K., Choi, G. S., Shin, J., Lee, H. J., Kim, D. H., Kim, T. H., et al. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.3.719 · Cited by 111
Harris, J. E. (2016) · Immunological Reviews · doi:10.1111/imr.12369 · Cited by 110
Cavalli, G., Hayashi, M., Jin, Y., Yorgov, D., Santorico, S. A., Holcomb, C. L., Rastrou, M. V., Erlich, H., Tengesdal, I. W., Dagna, L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523482113 · Cited by 110
Characteristics of genetic epidemiology and genetic models for vitiligo
Zhang, X.-J., Liu, J., Gui, J.-P., Li, M., Xiong, Q.-G., Wu, H., Li, J., Yang, S., Wang, H., Gao, M., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.12.044 · Cited by 107
Hamidizadeh, N., Ranjbar, S., Ghanizadeh, A. J., Parvizi, M. M., Jafari, P., & Handjani, F. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-1278-7 · Cited by 107
Dermoscopy in vitiligo: diagnosis and beyond
Jha, A. K., Sonthalia, S., Lallas, A., & Chaudhary, R. K. P. (2017) · International Journal of Dermatology · doi:10.1111/ijd.13795 · Cited by 106
Epidemiology of vitiligo in the French West Indies (Isle of Martinique)
Boisseau‐Garsaud, A., Garsaud, P., Calès-Quist, D., et al. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00880.x · Cited by 105
Common variants in FOXP1 are associated with generalized vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Mailloux, C. M., Riccardi, S. L., Gowan, K., Holland, P. J., Bennett, D. C., Wallace, M. R., McCormack, W. T., et al. (2010) · Nature Genetics · doi:10.1038/ng.602 · Cited by 105
Self-citationvan Geel, N., Wallaeys, E., Goh, B. K., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10014.x · Cited by 104
Shared Genetic Relationships Underlying Generalized Vitiligo and Autoimmune Thyroid Disease
Spritz, R. A. (2010) · Thyroid · doi:10.1089/thy.2010.1643 · Cited by 103
Evidence-based management of vitiligo: summary of a Cochrane systematic review
Whitton, M. E., Pinart, M., Batchelor, J., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14356 · Cited by 103
Depigmentation therapies for normal skin in vitiligo universalis
AlGhamdi, K. M., & Kumar, A. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03876.x · Cited by 102
The Efficacy of Afamelanotide and Narrowband UV-B Phototherapy for Repigmentation of Vitiligo
Grimes, P. E., Hamzavi, I. H., Lebwohl, M., Ortonne, J. P., & Lim, H. W. (2012) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.386 · Cited by 102
Spritz, R. A. (2010) · Genome Medicine · doi:10.1186/gm199 · Cited by 102
Alterations of Mitochondria in Peripheral Blood Mononuclear Cells of Vitiligo Patients
Dell’Anna, M. L., Urbanelli, S., Mastrofrancesco, A., Camera, E., Iacovelli, P., Leone, G., Manini, P., d’Ischia, M., & Picardo, M. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00087.x · Cited by 101
Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients
Hofer, A., Hassan, A. S., Legat, F. J., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06321.x · Cited by 100
In Vitro Growth Characteristics of Melanocytes Obtained From Adult Normal and Vitiligo Subjects
Puri, N., Mojamdar, M. V., & Ramaiah, A. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12469795 · Cited by 98
Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms
Gey, A., Diallo, A., Sénéschal, J., Léauté-Labrèze, C., Boralévi, F., Jouary, T., Taïeb, A., & Ezzedine, K. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12166 · Cited by 97
Self-citationTRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress
Kang, P., Zhang, W., Chen, X., Yi, X., Song, P., Chang, Y., Zhang, S., Gao, T., Li, C., & Li, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.022 · Cited by 96
MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo
Sahoo, A., Lee, B., Boniface, K., Sénéschal, J., Sahoo, S. K., Seki, T., Wang, C., Das, S., Han, X., Steppie, M., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.025 · Cited by 95
Kemp, E. H., Gawkrodger, D. J., Watson, P. F., et al. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4781381.x · Cited by 94
Genetic Variation of Promoter Sequence Modulates XBP1 Expression and Genetic Risk for Vitiligo
Ren, Y., Yang, S., Xu, S., Gao, M., Huang, W., Gao, T., Fang, Q., Quan, C., Zhang, C., Sun, L., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000523 · Cited by 94
Arcos‐Burgos, M., Parodi, E., Salgar, M., Bedoya, E., Builes, J. J., J., D. E. J., Gabriel Ceballos, C., Uribe, A., Rivera, N., Rivera, D., et al. (2002) · Human Genetics · doi:10.1007/s00439-002-0687-5 · Cited by 94
Inflammasome activation and vitiligo/nonsegmental vitiligo progression
Marie, J., Kovacs, D., Pain, C., Jouary, T., Cota, C., Vergier, B., Picardo, M., Taı̈eb, A., Ezzedine, K., & Cario, M. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12691 · Cited by 93
Self-citationA Practical Approach to the Diagnosis and Treatment of Vitiligo in Children
Ezzedine, K., & Silverberg, N. B. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4126 · Cited by 92
Self-citationCCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo
Eby, J. M., Kang, H.-K., Tully, S. T., Bindeman, W. E., Peiffer, D. S., Chatterjee, S., Mehrotra, S., & Poole, I. C. L. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.26 · Cited by 91
CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice
Richmond, J. M., Masterjohn, E., Chu, R., Tedstone, J., Youd, M. E., & Harris, J. E. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.10.048 · Cited by 91
Clinical significance of Koebner phenomenon in vitiligo
van Geel, N., Speeckaert, R., Wolf, J. D., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11158.x · Cited by 90
Betterle, C., Caretto, A., Zio, A. D., et al. (2009) · Dermatologica · doi:10.1159/000249466 · Cited by 89
Modern vitiligo genetics sheds new light on an ancient disease
Spritz, R. A. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12147 · Cited by 87
Jin, Y., Roberts, G. H. L., Ferrara, T. M., Ben, S., van Geel, N., Wolkerstorfer, A., Ezzedine, K., Siebert, J., Neff, C. P., Palmer, B. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08337-4 · Cited by 87
Self-citationInterfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.
Rashighi, M., & Harris, J. E. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.11.36 · Cited by 86
Current aspects of vitiligo genetics
Czajkowski, R., & Męcińska‐Jundziłł, K. (2014) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2014.43497 · Cited by 85
Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo
Sosa, J. J., Currimbhoy, S. D., Ukoha, U. T., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.014 · Cited by 83
A central role for inducible heat‐shock protein 70 in autoimmune vitiligo
Mosenson, J. A., Eby, J. M., Hernandez, C., & Poole, I. C. L. (2013) · Experimental Dermatology · doi:10.1111/exd.12183 · Cited by 83
Dell’Anna, M. L., Ottaviani, M., Bellei, B., Albanesi, V., Cossarizza, A., Rossi, L. C., & Picardo, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22027 · Cited by 83
Eleftheriadou, V., Thomas, K. S., Whitton, M. E., Batchelor, J., & Ravenscroft, J. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11056.x · Cited by 83
Vitiligo prevalence study in Shaanxi Province, China
Lu, T., Gao, T., Wang, A., et al. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02848.x · Cited by 83
The convergence theory for vitiligo: A reappraisal
Kundu, R. V., Mhlaba, J. M., Rangel, S. M., & Poole, I. C. L. (2018) · Experimental Dermatology · doi:10.1111/exd.13677 · Cited by 83
The genetic architecture of vitiligo
Roberts, G. H. L., Santorico, S. A., & Spritz, R. A. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12848 · Cited by 81
Whitton, M. E., Pinart, M., Batchelor, J., Lushey, C., Leonardi‐Bee, J., & González, U. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003263.pub4 · Cited by 80
Preliminary evaluation of vitiligo using in vivo reflectance confocal microscopy
Ardigò, M., Malizewsky, I., Dell’Anna, M. L., Berardesca, E., & Picardo, M. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02275.x · Cited by 79
Erbium:YAG Laser and Cultured Epidermis in the Surgical Therapy of Stable Vitiligo
Guerra, L., Primavera, G., Raskovic, D., et al. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.10.1303 · Cited by 79
Ezzedine, K., Diallo, A., Léauté-Labrèze, C., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11002.x · Cited by 78
Self-citationLiving with vitiligo: results from a national survey indicate differences between skin phototypes
Ezzedine, K., Grimes, P. E., Meurant, J. ‐., Sénéschal, J., Léauté-Labrèze, C., Ballanger, F., Jouary, T., TAIEB, C., & Taı̈eb, A. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13839 · Cited by 78
Self-citationA Romanian Population Isolate With High Frequency of Vitiligo and Associated Autoimmune Diseases
Birlea, S. A., Fain, P. R., & Spritz, R. A. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.310 · Cited by 78
Ezzedine, K., Whitton, M. E., & Pinart, M. (2016) · JAMA · doi:10.1001/jama.2016.12399 · Cited by 78
Self-citationSurgical treatment of vitiligo: why, when and how
Falabella, R. (2003) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2003.00718.x · Cited by 77
Melanoma‐associated antigens recognized by cytotoxic T lymphocytes
Kirkin, A. F., Dzhandzhugazyan, K. N., & Zeuthen, J. (1998) · Apmis · doi:10.1111/j.1699-0463.1998.tb00210.x · Cited by 77
Halo Nevi Association in Nonsegmental Vitiligo Affects Age at Onset and Depigmentation Pattern
Diallo, A. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2011.351 · Cited by 75
Clinical and histopathologic characteristics of trichrome vitiligo
Hann, S. K., Kim, Y. S., Yoo, J. H., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90170-1 · Cited by 75
Nisticò, S. P., Chiricozzi, A., Saraceno, R., et al. (2011) · Photomedicine and Laser Surgery · doi:10.1089/pho.2011.3029 · Cited by 74
Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion
Poole, I. C. L., Wijngaard, R. M. J. G. V. D., Westerhof, W., et al. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.18011894.x · Cited by 74
IL‐17A is not a treatment target in progressive vitiligo
Speeckaert, R., Mylle, S., & van Geel, N. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12789 · Cited by 73
Batchelor, J., Tan, W., Tour, S. K., Yong, A., Montgomery, A. A., & Thomas, K. S. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14208 · Cited by 72
The utility of dermoscopy in the diagnosis of evolving lesions of vitiligo
Thatte, S., & Khopkar, U. S. (2014) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.144144 · Cited by 72
Clinical significance of Koebner’s phenomenon in vitiligo
van Geel, N., Speeckaert, R., Wolf, J. D., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11111.x · Cited by 71
400 cases of vitiligo. A clinico-therapeutic analysis.
Behl, P. N., & Bhatia, R. K. (1972) · PubMed · Cited by 70
Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression
Rezk, A. F., Kemp, D. M., El-Domyati, M. M., El‐Din, W. H., Lee, J. B., Uitto, J., Igoucheva, O., & Alexeev, V. Y. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.028 · Cited by 70
Clinical markers of vitiligo activity
Benzekri, L., & Gauthier, Y. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.040 · Cited by 70
Reliability and validity of the Vitiligo Signs of Activity Score (VSAS)
van Geel, N., Passeron, T., Wolkerstorfer, A., Speeckaert, R., & Ezzedine, K. (2020) · British Journal of Dermatology · doi:10.1111/bjd.18950 · Cited by 70
Self-citationBatçıoğlu, K., Ozturk, I., Karataş, F., Haznecı, E., & Genç, M. (2008) · Indian Journal of Dermatology · doi:10.4103/0019-5154.39577 · Cited by 69
Abdallah, M., El-Mofty, M. A., Anbar, T. S., Rasheed, H. M., Esmat, S. M., Al‐Tawdy, A., Fawzy, M. M., Abdel-Halim, D. M., Hegazy, R. A., Gawdat, H. I., et al. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12667 · Cited by 69
Lopes, C., Trevisani, V. F. M., & Melnik, T. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0164-2 · Cited by 68
Guidelines for the diagnosis and treatment of vitiligo in Japan
Oiso, N., Suzuki, T., Wataya‐Kaneda, M., et al. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12099 · Cited by 67
Studies on vitiligo. II. Familial aggregation and genetics
Das, S., Majumder, P. P., Majumdar, T. K., Haldar, B., & Rao, D. C. (1985) · Genetic Epidemiology · doi:10.1002/gepi.1370020303 · Cited by 66
Follicular vitiligo: A report of 8 cases
Gan, E. Y., Cario, M., Pain, C., Goussot, J., Taïeb, A., Sénéschal, J., & Ezzedine, K. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.049 · Cited by 65
Self-citationOpen‐label pilot study of tofacitinib 2% for the treatment of refractory vitiligo
Mobasher, P., Guerra, R., Li, S. J., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18606 · Cited by 65
Prevalence and Clinical Profile of Vitiligo in China: A Community-based Study in Six Cities
Wang, X., Du, J., Wang, T., Zhou, C., Shen, Y., Ding, X., Tian, S., Liu, Y., Peng, G., Xue, S., et al. (2013) · Acta Dermato Venereologica · doi:10.2340/00015555-1397 · Cited by 64
Mofty, A. M. E., & Mofty, M. E. (1980) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1980.tb00316.x · Cited by 62
Bae, J. M., Yoo, H. J., Kim, H., Lee, J. H., & Kim, G. M. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.008 · Cited by 60
Bae, J. M., Hong, B. Y., Lee, J. H., Lee, J. H., & Kim, G. M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.11.044 · Cited by 60
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference
Gan, E. Y., Eleftheriadou, V., Esmat, S. M., Hamzavi, I. H., Passeron, T., Böhm, M., Anbar, T. S., Goh, B. K., Lan, C.-C. E., Lui, H., et al. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12561 · Cited by 60
Self-citationA review of non-cultured epidermal cellular grafting in vitiligo
van Geel, N., Goh, B. K., Wallaeys, E., et al. (2011) · Journal of Cutaneous and Aesthetic Surgery · doi:10.4103/0974-2077.79181 · Cited by 59
Hayashi, M., Jin, Y., Yorgov, D., Santorico, S. A., Hagman, J. R., Ferrara, T. M., Jones, K. L., Cavalli, G., Dinarello, C. A., & Spritz, R. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525001113 · Cited by 57
New insight into the role of exosomes in vitiligo
Wong, P. M., Yang, L., Yang, L., Wu, H., Li, W., Ma, X., Katayama, I., & Zhang, H. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102664 · Cited by 57
HSP70iQ435A-Encoding DNA Repigments Vitiligo Lesions in Sinclair Swine
Henning, S. W., Fernandez, M. F., Mahon, J., Duff, R., Azarafrooz, F., Guevara-Patino, J. A., RADEMAKER, A. W., Salzman, A. L., & Poole, I. C. L. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.186 · Cited by 56
Cited by
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Rosmarin, D., Passeron, T., Pandya, A. G., Grimes, P., Harris, J. E., Desai, S. R., Lebwohl, M., Ruer-Mulard, M., Seneschal, J., Wolkerstorfer, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118828 · Cited by 316
Self-citationVitiligo prevalence and quality of life among adults in Europe, Japan, and the USA
Bibeau, K., Pandya, A. G., Ezzedine, K., Jones, H., Gao, J., Lindley, A., & Harris, J. E. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18257 · Cited by 137
Self-citationGuo, L., Yang, Y., Ding, H., Zheng, H., Yang, H., Xie, J., Li, Y., Lin, T., & Ge, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1738 · Cited by 62
“Repigmentation, either spontaneous or treatment-induced, may also take different forms and is often unevenly distributed (8,9).”
Metadata
- Authors
- Bergqvist, C., & Ezzedine, K.
- Venue
- The Journal of Dermatology
- Publisher
- Wiley
- Published
- 2021-01-06
- Volume
- 48
- Issue
- 3
- Pages
- 252-270
- ISSN
- 0385-2407 (ISSN-L)
- 1346-8138
- OpenAlex
- W3119509510
- Cited by
- 277
- References
- 236
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.